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Among epidermal growth factors, heparin-binding epidermal growth factor (EGF)-
like growth factor (HB-EGF) is expressed unlike others, and produces unusual
effects on keratinocytes. A new report illustrates the development of a motile
phenotype characterized by signs of epithelial–mesenchymal transition, reduced
proliferation, and altered expression of epidermal markers. We comment on
differences between endogenous HB-EGF and recombinant factor, about oppor-
tune and inopportune situations of HB-EGF overexpression by epidermal
keratinocytes, as well as about the consequences on epidermal tissues.
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Among members of the epidermal
growth factor (EGF) family of growth
factors produced in the epidermis, the
heparin-binding EGF-like growth factor
(HB-EGF) is one of the ligands for the
EGF receptor (EGFR) in keratinocytes
(Piepkorn et al., 1998). In this cell
type, HB-EGF may function differently
from other members of its family, as it
induces unique consequences. In a new
study based on lentiviral infection of
immortalized hTERT keratinocytes that
conditionally induces the expression of
HB-EGF, Stoll et al. (2012) report some
specific behaviors: enhanced expression
of HB-EGF produces a motile phenotype
in keratinocytes, with poor cell–cell
adhesion and elongated morphology
instead of their usual typical epithelial
cobblestone pattern. The report also
illustrates that this phenotype has simi-
larities with the epithelial–mesenchymal
transition that is observed during carci-
nogenesis in transformed epithelial cells.
Surprisingly, exposure of keratinocytes to
exogenous recombinant HB-EGF, even
at elevated concentrations, is unable to
fully induce the same phenotype, whereas
exposure to culture medium conditioned
by HB-EGF-overexpressing keratinocytes
leads to a motile phenotype, thereby
demonstrating the involvement of an addi-
tional released (soluble) growth factor.
Neutralization of HB-EGF in the condi-
tioned medium using a specific antibody,
or inhibition by GM6001 of the activity
of proteases required for the release of
soluble HB-EGF from its membrane pre-
cursor, causes disappearance of the motile
phenotype. Thus, these surprising observa-
tions reveal on one hand that a recom-
binant growth factor able to bind EGFRs
with high affinity is poorly active in modi-
fying keratinocyte phenotype into a motile
one, whereas on the other hand, low
concentrations of the endogenous growth
factor that is released into the extracellular
medium is sufficient to trigger the motile
phenotype.
Evidence for differences between
recombinant exogenous HB-EGF and
endogenous HB-EGF
Ligand-dependent activation of the EGFR
is likely required absolutely to induce
the motile phenotype, because blockade
of shedding, neutralization of HB-EGF,
or inhibition of the receptor’s tyrosine
kinase activity impedes development
of the motile phenotype. Thus, what
differences between recombinant HB-
EGF and endogenous factor explains
the data? Stoll et al. (2012) propose that
posttranslational modifications or conse-
quences of the shedding of HB-EGF
precursor would make the difference.
They also argue against a role for the
transmembrane precursor of HB-EGF.
Indeed, HB-EGF membrane and cyto-
plasmic moieties are left in the produ-
cing cell after shedding of the extracellu-
lar soluble growth factor. These moieties
could have interfered with cell signaling
after autocrine activation of the EGFR
at the surface of keratinocytes. Instead,
collaboration with a cofactor, also
released by keratinocytes overexpressing
HB-EGF, and which could drive HB-EGF
to signal differently, cannot be excluded.
Published data suggest that hyaluronic
acid for instance may be a candidate
(Barnes et al., 2010).
HB-EGF slows keratinocyte proliferation
and favors a motile phenotype
In other respects, Stoll et al. (2012) further
illustrate reduced cell growth in kerati-
nocytes induced to overexpress HB-EGF.
This is a rather surprising observation with
respect to the potential autocrine role
of HB-EGF on keratinocytes (Piepkorn
et al., 1998), which is mainly thought
to stimulate cell proliferation and tissue
hyperplasia, after retinoid treatment for
instance (Rittie´ et al., 2006).
Thus, unusual consequences of HB-EGF
production and release can be expected in
epidermal tissues. Exposure of keratino-
cytes to HB-EGF increases their expression
of HB-EGF. With respect to wound heal-
ing, acceleration of keratinocyte migration
and quicker epidermal repair were obser-
ved upon incubation with HB-EGF
(Shirakata et al., 2005). Accordingly, we
reported elevated HB-EGF expression at
the margins of healing epidermal wounds
(Mathay et al., 2008), and similar eleva-
tions in HB-EGF expression are now
reported to occur in the regenerating epi-
dermis after laser capture microdissection
(Stoll et al., 2012). Such a beneficial effect
of HB-EGF during tissue repair appears
to be in perfect concordance with its indu-
ced expression in vivo or in vitro (Stoll
et al., 2012). It now appears that, unlike
other growth factors involved in tissue
repair, such as platelet-derived growth
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factor, the main effect of HB-EGF lies in
the induction of a motile phenotype,
uncoupled from cell proliferation, which
leads keratinocytes to re-epithelialize skin
wounds before they become proliferative.
Stoll et al. (2012) further report that
the induced HB-EGF expression in
keratinocytes is concomitant with the
inhibition of the expression of keratins,
especially the suprabasal epidermal
keratins 1 and 10. Such a downregu-
lation of keratin 10 expression by HB-
EGF in cultured keratinocytes, as well
as the lack of expression of keratin 10
by keratinocytes producing HB-EGF in
the migrating epidermal margins, has
been reported to occur during healing
(Mathay et al., 2008). In addition, other
reports confirm reduced expression of
suprabasal keratins when HB-EGF
expression is upregulated. For instance,
Stoll and Elder (1998) have reported
stimulated HB-EGF expression after
exposure of epidermal keratinocytes to
retinoic acid. Concomitant inhibition of
keratin 10 expression by retinoic acid
in autocrine cultures of keratinocytes
has been demonstrated (Giltaire et al.,
2009). Furthermore, cholesterol deple-
tion in keratinocyte plasma membranes
also results in overexpression of HB-
EGF, associated with the inhibition of
keratin 10 expression (Mathay et al.,
2008, 2011).
HB-EGF expression in challenged
keratinocytes
Thus, it appears that epidermal kerati-
nocytes challenged by various altera-
tions in their environment behave in a
similar manner and exhibit stimulation
of their endogenous expression of HB-
EGF. This is concomitant with stimula-
tion of the expression of other gene
products, such as interleukin-8 after
cholesterol depletion (Mathay et al.,
2011) or exposure to sensitizing chemi-
cals (Frankart et al., 2012), matrix metallo-
proteases 1 and 10 (Mathay et al., 2011;
Stoll et al., 2012), and even more
surprisingly, involucrin (Mathay et al.,
2008; Giltaire et al., 2009; Mathay et al.,
2011). Now, Stoll et al. (2012) reveal that
keratinocytes overexpressing HB-EGF are
very likely triggered toward a motile,
abnormally differentiated, but also poorly
proliferative, phenotype. These results
seem fully consistent with observations
made during cutaneous healing at wound
margins, where HB-EGF-producing kerati-
nocytes are rather motile, exhibit altered
differentiation, and do not proliferate
(while in this location). Nevertheless, it
is interesting to note that treatment condi-
tions, such as exposure to retinoic acid,
or disease conditions, such as atopic
dermatitis and psoriasis, associated with
an elevated expression of HB-EGF by
keratinocytes, also exhibit altered differen-
tiation, but are characterized in vivo by
epidermal hyperplasia (Rittie´ et al., 2006;
Mathay et al., 2011). This suggests that
some of the observations made for kerati-
nocytes cultured in low-calcium medium
may not correspond to the behavior of
cohesive keratinocytes in vivo. In fact,
except for the wound healing, over-
expression of HB-EGF could probably
reflect an inopportune epidermal response.
The role of keratinocytes in over-
expression of HB-EGF is complex.
Although Stoll et al. (2012) contribute
by uncovering new features linked to
this epidermal factor, some partners
and involved strategies remain hidden,
complicating our current understanding
of growth factor biology.
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Clinical Implications
When overexpressed by keratinocytes, HB-EGF deregulates the cell
phenotype.
 HB-EGF promotes epidermal wound healing while retarding keratinocyte
proliferation.
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